BioCatalystWatch
SUPNWorkspace / SUPN / OverviewCompany library
SUPERNUS PHARMACEUTICALS, INC. logo

SUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Website

Price
Market cap
Next catalystExpected 2026SPN-817 · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

SPN-443

PreINDP2P3FilingApproved
Upcoming / outlook

SPN-817

Acetylcholinesterase (AChE)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SPN-817

Acetylcholinesterase (AChE)

PreINDP1P2P3FilingApproved
Upcoming / outlook

SPN-443

PreINDP2P3FilingApproved
Upcoming / outlook

Other pipelines

SPN-817

Acetylcholinesterase (AChE)

SPN-820

Sestrin proteins × mTORC1

PreINDP1P2P3FilingApproved
SPN-817

Acetylcholinesterase (AChE)

SPN-446

PreINDP1P2P3FilingApproved

Partner / License out

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved / commercial

Postsynaptic dopamine receptors

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Monoamine oxidase B (MAO-B)

Approved

PreINDP1P2P3FilingApproved

History / paused

SPN-820

Sestrin proteins × mTORC1

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SUPN PR & News

PR & News

SUPN SEC archive